Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biocept Inc BIOCQ

Healthcare Biotechnology
Biocept, Inc. is a molecular oncology diagnostics company. The Company focuses on developing and commercializing clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor deoxyribonucleic acid (DNA) from blood and cerebrospinal fluid (CSF). Its product is branded and trademarked under the name CNSide. CNSide encompasses a suite of cellular and molecular... see more

Recent & Breaking News (GREY:BIOCQ)

Biocept, Inc. Announces Closing of Initial Public Offering

GlobeNewswire February 10, 2014

BioClinica and CoreLab Partners Are One

Business Wire March 14, 2013

BioClinica, Inc. and JLL Partners, Inc. Announce Successful Completion of Tender Offer

Business Wire March 12, 2013

Medtentia International and clinicalprojects international Tap BioClinica for Express EDC, Data Management, and Centralized Imaging Reads

Business Wire March 4, 2013

BioClinica, Inc. and JLL Partners, Inc. Announce Early Termination of Hart-Scott-Rodino Act Waiting Period

Business Wire February 21, 2013

Cash Tender Offer to Acquire BioClinica, Inc. at $7.25 Per Share Commenced by an Affiliate of JLL Partners, Inc.

Business Wire February 11, 2013

BioClinica Announces Fourth Quarter and Full Year 2012 Financial Results

Business Wire February 6, 2013

BioClinica to Release Fourth Quarter and Year-End 2012 Financial Results on February 6, 2013

Business Wire February 4, 2013

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of BioClinica, Inc. in Connection with the Sale of the Company to JLL Partners, Inc.

PR Newswire February 1, 2013

Law Firm Brower Piven Announces Investigation of BioClinica, Inc.

Business Wire January 31, 2013

Rigrodsky & Long, P.A. Announces Investigation Of BioClinica, Inc. Buyout

Business Wire January 31, 2013

Acquisition of BioClinica, Inc. by JLL Partners, Inc. May Not Be in BioClinica, Inc. Shareholders' Best Interests

PR Newswire January 31, 2013

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of BioClinica, Inc. in Connection with the Sale of the Company to JLL Partners, Inc.

Business Wire January 31, 2013

Ryan & Maniskas, LLP Announces Investigation of BioClinica, Inc.

PR Newswire January 31, 2013

Law Office of Brodsky & Smith, LLC Announces Investigation of BioClinica, Inc.

PR Newswire January 30, 2013

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of BioClinica, Inc. Shareholders

Business Wire January 30, 2013

WeissLaw LLP Investigates BioClinica, Inc. Acquisition

Business Wire January 30, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of BioClinica Inc. - BIOC

PR Newswire January 30, 2013

Finkelstein Thompson LLP Announces Investigation of BioClinica, Inc.

Business Wire January 30, 2013

Harwood Feffer LLP Announces Investigation of BioClinica, Inc.

PR Newswire January 30, 2013